Brief: CombiGene Signs Agreement With British Neurochase

Larkberget AB

23/11/2020 09:19

Nov 23 (Reuters) - Combigene AB  COMBI.ST :
    * COMBIGENE SIGNS AGREEMENT WITH BRITISH NEUROCHASE FOR
OPTIMIZED
ADMINISTRATION OF CG01, A GENE THERAPY DEVELOPED FOR TREATMENT
OF FOCAL EPILEPSY
    * WILL CONDUCT  STUDIES TO OPTIMIZE INFUSION STRATEGY SO
THAT
POTENTIALLY GROUNDBREAKING EPILEPSY TREATMENT CAN BE SAFELY
ADMINISTERED

Source text: https://bit.ly/2USTDBq
Further company coverage:  COMBI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))